- Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
-
Park J, Cheon JH
- KMID: 2382371
- Intest Res.
- 2017 Jul;15(3):263-265.
- doi: 10.5217/ir.2017.15.3.263
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
-
Lee HJ, Cheon JH
- KMID: 2382374
- Intest Res.
- 2017 Jul;15(3):311-317.
- doi: 10.5217/ir.2017.15.3.311
Intestinal Behçet's disease (BD), generally accepted as a type of inflammatory bowel disease (IBD), could be diagnosed when patients with BD have objectively documented gastrointestinal symptoms and intestinal ulcerations. Similar... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
-
Hisamatsu , Hayashida
- KMID: 2382375
- Intest Res.
- 2017 Jul;15(3):318-327.
- doi: 10.5217/ir.2017.15.3.318
Behçet's disease (BD) is a chronic relapsing disease involving multiple organ systems. BD is characterized clinically by oral and genital aphthae, cutaneous lesions, and ophthalmological, neurological, and/or gastrointestinal manifestations. It... -
- CITED
-
- Close
- SHARE
-
- Close
- Asymptomatic multiple cystic lesions filled with gas in the colon
-
Kim KB, Yoon SM
- KMID: 2382389
- Intest Res.
- 2017 Jul;15(3):429-430.
- doi: 10.5217/ir.2017.15.3.429
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial
-
Inoue N, Kobayashi , Naganuma M, Hirai F, Ozawa M, Arikan D, Huang B, Robinson A, Thakkar RB, Hibi T
- KMID: 2382384
- Intest Res.
- 2017 Jul;15(3):395-401.
- doi: 10.5217/ir.2017.15.3.395
BACKGROUND/AIMS: Intestinal Behçet's disease (BD) is an immune-mediated inflammatory disorder. We followed up the patients and evaluated safety profile and effectiveness of adalimumab for the treatment of intestinal BD through... -
- CITED
-
- Close
- SHARE
-
- Close
- Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
-
Mandavdhare HS, Sharma V, Prasad KK, Kumar A, Rathi M, Rana SS
- KMID: 2382387
- Intest Res.
- 2017 Jul;15(3):419-421.
- doi: 10.5217/ir.2017.15.3.419
Recent studies have identified sprue-like illness associated with the use of the antihypertensive agent olmesartan medoxomil. However, whether this condition is specific to the use of olmesartan or is associated... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases
-
Kim YS, Jung SA, Lee KM, Park SJ, Kim TO, Choi CH, Kim HG, Moon W, Moon CM, Song HK, Na SY, Yang SK, Korean Association for the Study of Intestinal Diseases (KASID)
- KMID: 2382377
- Intest Res.
- 2017 Jul;15(3):338-344.
- doi: 10.5217/ir.2017.15.3.338
BACKGROUND/AIMS: Inflammatory bowel disease (IBD) is a chronic disabling gastrointestinal disorder that diminishes the quality of life of the affected individuals. Limited data are available regarding the impact of IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
-
Sato T, Takagawa T, Kakuta Y, Nishio A, Kawai M, Kamikozuru K, Yokoyama Y, Kita Y, Miyazaki T, Iimuro M, Hida N, Hori K, Ikeuchi H, Nakamura S
- KMID: 2382376
- Intest Res.
- 2017 Jul;15(3):328-337.
- doi: 10.5217/ir.2017.15.3.328
BACKGROUND/AIMS: Recent genome-wide analyses have provided strong evidence concerning adverse events caused by thiopurine drugs such as azathioprine (AZA) and 6-mercaptopurine. The strong associations identified between NUDT15 p.Arg139Cys and thiopurine-induced... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study
-
Ogata H, Ohori A, Nishino H, Mizushima , Hagino A, Hibi T
- KMID: 2382380
- Intest Res.
- 2017 Jul;15(3):358-367.
- doi: 10.5217/ir.2017.15.3.358
BACKGROUND/AIMS: This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission. METHODS: In this multicenter, randomized, double-blind study, 203 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
-
Gupta A, Bopanna S, Kedia S, Yadav DP, Goyal S, Jain S, Makharia G, Ahuja V
- KMID: 2382383
- Intest Res.
- 2017 Jul;15(3):388-394.
- doi: 10.5217/ir.2017.15.3.388
BACKGROUND/AIMS: Familial occurrence of inflammatory bowel disease (IBD) is well documented. Reports from Western countries have shown a higher familial occurrence of ulcerative colitis (UC) in first- and second-degree relatives... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study
-
Ogata H, Aoyama N, Mizushima , Hagino A, Hibi T
- KMID: 2382381
- Intest Res.
- 2017 Jul;15(3):368-379.
- doi: 10.5217/ir.2017.15.3.368
BACKGROUND/AIMS: This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) compared to another form of high-dose mesalazine. METHODS: In this multicenter, randomized, double-blind study, 280 patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Behçet's disease with multiple splenic abscesses in a child
-
Lim KI, Yang DH, Ryoo E
- KMID: 2382388
- Intest Res.
- 2017 Jul;15(3):422-428.
- doi: 10.5217/ir.2017.15.3.422
We report the case of a 5-year-old male patient with multiple aseptic splenic abscesses associated with Behçet's disease. The patient visited Gachon University Gil Hospital with fever, abdominal pain, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Japanese physicians' attitudes towards enteral nutrition treatment for pediatric patients with Crohn's disease: a questionnaire survey
-
Ishige T, Tomomasa T, Tajiri H, Yoden A, Japanese Study Group for Pediatric Crohn's Disease
- KMID: 2382378
- Intest Res.
- 2017 Jul;15(3):345-351.
- doi: 10.5217/ir.2017.15.3.345
BACKGROUND/AIMS: Enteral nutrition (EN) is recommended for the treatment of pediatric Crohn's disease (CD) in Japan. However, the indications and treatment protocols for EN vary among hospitals. In the present... -
- CITED
-
- Close
- SHARE
-
- Close
- Ophthalmologic manifestations in patients with inflammatory bowel disease
-
Lee HJ, Song HJ, Jeong JH, Kim HU, Boo SJ, Na SY
- KMID: 2382382
- Intest Res.
- 2017 Jul;15(3):380-387.
- doi: 10.5217/ir.2017.15.3.380
BACKGROUND/AIMS: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), has been reported to have various ophthalmologic manifestations. The aim of this study was to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients
-
Kim ER, Jeon J, Lee JH, Lee YJ, Hong SN, Chang DK, Kim YH
- KMID: 2382385
- Intest Res.
- 2017 Jul;15(3):402-410.
- doi: 10.5217/ir.2017.15.3.402
BACKGROUND/AIMS: Serrated polyposis syndrome (SPS) has been shown to increase the risk of colorectal cancer (CRC). However, little is known about the characteristics of Asian patients with SPS. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies
-
Kim NH, Jung YS, Jeong WS, Yang HJ, Park SK, Choi K, Park DI
- KMID: 2382386
- Intest Res.
- 2017 Jul;15(3):411-418.
- doi: 10.5217/ir.2017.15.3.411
BACKGROUND/AIMS: Colonoscopic polypectomy is the best diagnostic and therapeutic tool to detect and prevent colorectal neoplasms. However, previous studies have reported that 17% to 28% of colorectal polyps are missed... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease
-
Magro DO, Kotze PG, Martinez C, Camargo MG, Guadagnini D, Calixto AR, Vasques AC, Ayrizono M, Geloneze B, Pareja JC, Saad MJ, Coy CS
- KMID: 2382379
- Intest Res.
- 2017 Jul;15(3):352-357.
- doi: 10.5217/ir.2017.15.3.352
BACKGROUND/AIMS: Lipopolysaccharide (LPS) is a molecule formed by lipids and polysaccharides and is the major cell wall component of gram-negative bacteria. High LPS levels are known to block CD26 expression... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
-
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM
- KMID: 2382372
- Intest Res.
- 2017 Jul;15(3):266-284.
- doi: 10.5217/ir.2017.15.3.266
Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
-
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM
- KMID: 2382373
- Intest Res.
- 2017 Jul;15(3):285-310.
- doi: 10.5217/ir.2017.15.3.285
Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have... -
- CITED
-
- Close
- SHARE
-
- Close
